Sexual Functioning After Erection Prosthesis Placement in Post Phalloplasty Transgender Persons
Launched by UNIVERSITY HOSPITAL, GHENT · Oct 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how satisfied transgender men and their partners are with sexual functioning after they have had an erection prosthesis placed following phalloplasty, a surgery that creates a neophallus. The study recognizes that while these prostheses are meant to help with erectile dysfunction, they may have higher risks of complications compared to those used by cisgender men. Researchers want to understand how these devices affect both the sexual experiences of transgender men and their partners. They will use surveys to gather feedback from participants who have had their prosthesis for at least six months.
To be eligible for the study, participants need to be at least 18 years old, identify as transgender or gender non-conforming, and have undergone phalloplasty, along with having a working erection prosthesis for at least six months. Participants should be able to communicate in Dutch, English, or French and must provide written consent to join the study. If you or someone you know meets these criteria, this research could provide valuable insights into the sexual satisfaction and relationship dynamics of transgender individuals following this kind of surgery.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patient and partner age ≥ 18 years.
- • Transgender or gender non-conforming individuals diagnosed according to the DSM-5 diagnostic criteria for gender dysphoria.
- • Patients have undergone phalloplasty as a form of genital gender affirming surgery (any type of flap combination or technique is allowed).
- • Erection prosthesis placement ≥ 6 months after phalloplasty, performed at the Ghent University Hospital. Any type of prosthesis is allowed.
- • Patient has a functional erectile prosthesis at the time of the study. Number of erectile prosthesis is not relevant for inclusion.
- • Patient is Dutch, English or French speaking.
- • Voluntary signed and written consent by patient and their optional partner.
- Exclusion Criteria:
- • Patient age \< 18 years.
- • Cisgender patients treated with phalloplasty and/or erection prosthesis for various reasons.
- • The erection prosthesis has been explanted or the current prosthesis is nonfunctional at time of data assessment.
- • Erection prosthesis placement \< 6 months before study start will be excluded.
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, East Flanders, Belgium
Patients applied
Trial Officials
Anne-Françoise Spinoit, MD, PhD
Principal Investigator
University Hospital, Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported